Humanized IgG1 monoclonal antibody against GD2 clinical trials

A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma

This study is looking at a new treatment called Naxitamab for children and young people recently diagnosed with a serious type of cancer called neuroblastoma. It aims to see if adding Naxitamab to their usual first treatment helps shrunk the cancer more effectively.